MDLN
Medline Inc. · NASDAQ
- Market cap
- $51.52B
52-week range40% up the range
$31.42$50.84
Medline Inc. (MDLN) is a Medical/Dental Instruments company listed on NASDAQ. In the last 30 days Quantisnow tracked 14 wire items for MDLN, including 4 SEC filings, 4 insider trades and 2 press releases and news items. The most recent was published Nov 16, 2026.
MDLN rankings
Price$39.15+3.44 (+9.63%)
2026-08-142026-11-16
Financial highlights
Full financials- Revenue, TTM
- $30.68B
- Net income, TTM
- $683.00M
- Net margin
- 2.2%
- Free cash flow, TTM
- $1.90B
- Cash
- $2.32B
For the twelve months ended Sep 26, 2026, from SEC filings. Not investment advice.
News · 26 weeks66+63%
2026-05-242026-11-15
Mix2590d
- Insider8(32%)
- Other7(28%)
- SEC Filings5(20%)
- Earnings2(8%)
- 13D/G2(8%)
- Offering1(4%)
Activity · 52 weeks18872 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- INSIDERChief Legal Officer Liberman Alexander M. was granted 798,680 units of Class B Common Stock, increasing direct ownership by 352% to 1,025,603 units (SEC Form 4)4 - Liberman Alexander M. (CIK 0001460217)
- INSIDERChief Product Officer Laabs Amanda H. was granted 520,127 units of Class B Common Stock, increasing direct ownership by 207% to 771,197 units (SEC Form 4)4 - Laabs Amanda H. (CIK 0002061266)
- INSIDERChief Commercial Officer Golwas Douglas P was granted 895,512 units of Class B Common Stock, increasing direct ownership by 164% to 967,560 units (SEC Form 4)4 - Golwas Douglas P (CIK 0002061504)
- INSIDERChief Executive Officer Boyle James M was granted 2,516,260 units of Class B Common Stock, increasing direct ownership by 7,591% to 1,869,921 units (SEC Form 4)4 - Boyle James M (CIK 0002061052)
- PRMedline Inc. announces launch of secondary offering of Class A common stockNORTHFIELD, Ill., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc. and Hellman & Friedman LLC along with GIC Private Limited and its managed affiliate and a wholly owned subsidiary of the Abu Dhabi Investment Authority (collectively, the "Selling Stockholders") have commenced an underwritten public offering of 60,000,000 shares of Medline’s Class A common stock (the "Offering") pursuant to a registration statement filed with the Securities and Exchange Commission (the "SEC"). Additionally, the Selling Stockholders intend to grant the underwriters a 30-day option
- SECSEC Form S-1 filed by Medline Inc.S-1 - Medline Inc. (0002046386) (Filer)
- 13D/GSEC Form SCHEDULE 13G filed by Medline Inc.SCHEDULE 13G - Medline Inc. (0002046386) (Subject)
- 13D/GAmendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.SCHEDULE 13G/A - Medline Inc. (0002046386) (Subject)
- SECSEC Form 10-Q filed by Medline Inc.10-Q - Medline Inc. (0002046386) (Filer)
- SECMedline Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Medline Inc. (0002046386) (Filer)
- PRMedline Reports Third Quarter and Nine Months 2026 ResultsThird quarter net sales of $7.9 billion, an increase of 10.4%Third quarter net income of $318 million, a decrease of 1.2%Third quarter Adjusted EBITDA1 of $1.0 billion, an increase of 11.8%Nine months net sales of $22.9 billion, an increase of 10.9%Nine months net income of $696 million, a decrease of 28.8%Nine months Adjusted EBITDA1 of $2.8 billion, an increase of 5.0%Raising full year 2026 Organic Sales2 guidance to 10.0% to 10.5% from 9.0% to 10.0% and reaffirming Adjusted EBITDA2 guidance of $3.3 billion to $3.4 billionBoard of Directors authorized a $1 billion share repurchase program NORTHFIELD, Ill., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline" or the "Company") (NASD
- PRMedline announces participation in the 2026 Jefferies Global Healthcare ConferenceNORTHFIELD, Ill., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that Jim Boyle, chief executive officer, is scheduled to present at the Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026, at 3:30pm Greenwich Mean Time (GMT). A webcast of the presentation will be available on the Events page of Medline’s Investor Relations website at ir.medline.com. A replay of the webcast will be available on Medline’s Investor Relations website for 120 days following the event. About MedlineMedline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its broad product por
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.SCHEDULE 13G/A - Medline Inc. (0002046386) (Subject)
- SECSEC Form 8-K filed by Medline Inc.8-K - Medline Inc. (0002046386) (Filer)
- SECSEC Form 8-K filed by Medline Inc.8-K - Medline Inc. (0002046386) (Filer)
- PRMedline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.State-of-the-art facility planned to reinforce Medline's supply chain resilience in MichiganNORTHFIELD, Ill., Oct. 15, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, has announced plans to open a new distribution center in Van Buren Township, Mich., a suburb of Detroit. The approximately 800,000-square-foot facility represents a new company investment in Michigan and the overall Medline distribution network, adding capacity and operational flexibility as Medline invests to support its own growth and the evolving needs of healthcare providers across all points of care."This investment in Van
- INSIDERLarge owner Gic Private Ltd sold $274,767,093 worth of shares (7,816,987 units at $35.15) (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- PRMedline launches enhanced TrackPoint™ to simplify inventory management for post-acute careCombines real-time inventory tracking with PointClickCare® integration to reduce manual work and improve supply visibilityNORTHFIELD, Ill., Oct. 12, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) today announced the launch of an enhanced version of TrackPoint™, its online inventory management and patient item usage solution designed to help long-term care and inpatient hospice providers more easily track supplies from Medline, capture patient-level usage and gain visibility into inventory across locations.TrackPoint provides an easy-to-use solution that helps facilities streamline how they order and manage supplies purchased from Medline. The platform gives providers greater control over supply
- INSIDERLarge owner Gic Private Ltd sold $721,644,227 worth of shares (20,678,630 units at $34.90) (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- PRMEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share DropThe law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Medline Inc. ("Medline" or the "Company") (NASDAQ:MDLN) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE FIRM’S INVESTIGATION]What Happened?On June 2, 2026, the FDA published a warning letter that detailed Medline’s "significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals," including failing "to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications
- PRMedline to report third quarter 2026 results on November 4, 2026NORTHFIELD, Ill., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that it plans to report third quarter 2026 financial results on Wednesday, November 4, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results. Information about Medline’s financial results, including a link to the live webcast, will be available on the Events page of Medline’s Investor Relations website at ir.medline.com. A replay of the webcast will be available following the event through the same website. About MedlineMedline is the larges
- PRINVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law FirmMedline Inc. (NASDAQ:MDLN) shareholders should email fletcher@fmoorelaw.com NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- What is the Investigation About? On June 2, 2026, the Federal Drug Administration ("FDA") published a warning letter dated May 28, 2026 addressed to Medline summarizing "significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals[.]" The FDA further states that Medline "failed to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications." Following this news, the price of Medline stock fell $2.56 per share, or 7.16%, to close at $33.19 per share on Ju
- PRMedline announces participation in the Morgan Stanley 24th Annual Global Healthcare ConferenceNORTHFIELD, Ill., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that Jim Boyle, chief executive officer, and Mike Drazin, chief financial officer, are scheduled to present at the Morgan Stanley 24th Annual Global Healthcare Conference in New York, NY, on Tuesday, September 15, 2026, at 12:20pm ET. A webcast of the presentation will be available on the Events page of Medline’s Investor Relations website at ir.medline.com. A replay of the webcast will be available on Medline’s Investor Relations website for 90 days following the event. About MedlineMedline is the largest provider of medical-surgical products and supply chain solutions serving all
- INSIDERSEC Form 4 filed by Chief Executive Officer Boyle James M4 - Medline Inc. (0002046386) (Issuer)
- INSIDERSEC Form 4 filed by Chief Operating Officer Miller Stephen L4 - Medline Inc. (0002046386) (Issuer)
MDLN FAQ
10 questionsWhat is the latest news on MDLN?
In the last 30 days Quantisnow tracked 14 wire items for MDLN: 4 SEC filings, 4 insider trades, 2 press releases and news items and 2 13D/G filings. The most recent was published on November 16, 2026.What is MDLN revenue?
Medline Inc. (MDLN) reported $30.68B of revenue for the twelve months ended Sep 26, 2026. Revenue for fiscal 2025 was $28.43B.Is MDLN profitable?
Yes. Medline Inc. earned $683.00M in net income for the twelve months ended Sep 26, 2026, a net margin of 2.2%.How much cash and debt does MDLN have?
Medline Inc. reported $2.32B in cash and cash equivalents and $12.58B of debt on its most recent balance sheet in SEC filings.Where does MDLN stock trade?
Medline Inc. (MDLN) is listed on NASDAQ.What sector and industry is MDLN in?
Medline Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Medline Inc. go public?
Medline Inc. (MDLN) completed its IPO in 2025.What are analysts saying about MDLN?
Medline Inc. has had 8 recent analyst actions on file. The most recent action was from Citigroup: Buy with a $60.00 price target on 2026-03-11. Recent price targets range from $38.00 to $60.00.What companies are similar to MDLN?
Notable peers in the same industry include CAH (Cardinal Health Inc.), SYK (Stryker Corporation), BDX (Becton Dickinson and Company), ICUI (ICU Medical Inc.), TFX (Teleflex Incorporated). Compare MDLN side-by-side with any of them on Quantisnow.How can I track MDLN on Quantisnow?
Quantisnow aggregates Medline Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MDLN to receive live email and push alerts on every new disclosure.